Crossmark

Persistent Atrial Fibrillation Ablation: Ongoing Challenges Defining the Target Population and Substrate

Published Online: 2023-09-15

Published Print: 2023-10

Authors

Griffin, Michael https://orcid.org/0009-0007-8510-2944
Calvert, Peter

Gupta, Dhiraj
License Information

Text and Data Mining valid from 2023-09-15

Version of Record valid from 2023-09-15
More Information

Article History

Accepted: 14 August 2023

First Online: 15 September 2023

Compliance with Ethical Standards

:

: Michael Griffin declares that he has no conflict of interest. Peter Calvert declares that he has no conflict of interest Dhiraj Gupta is the speaker for Boehringer Ingelheim, Biosense Webster and Boston Scientific; the proctor for Abbott and has received research grants from Medtronic, Biosense Webster and Boston Scientific.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current